课题基金 / 基金详情

In vivo HGF gene transfer promoted liver regeneration and inhibited lethal liver failure after massive hepatectomy in rats with cirrhosis

In vivo HGF gene transfer promoted liver regeneration and inhibited lethal liver failure after massive hepatectomy in rats with cirrhosis
体内 HGF 基因转移促进肝硬化大鼠肝再生并抑制大规模肝切除术后的致死性肝衰竭
批准号:
13671358
负责人:
UEKI Takahiro
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background/Aim : Liver surgery is accepted as one of the potentially curative treatments for hepatocellular carcinoma. However, most patients have coexisting cirrhosis and impaired liver reserve function. Therefore, massive hepatectomy often causes lethal liver failure post operation in cirrhotic liver. Hepatocyte growth factor (HGF) is known to be a potent mitogen in hepatocyte and play an important roll in liver regeneration. In the present study, we delivered HGF gene to cirrhotic rat liver, and investigated whether HGF gene transduction prevents lethal liver failure after hepatectomy.Method : Liver cirrhosis was induced by administrating 1% dimethylnitrosamine (DMN) on 3 consecutive days a week for 4 weeks. Three days after the final injection of DMN, 20 μg of HGF gene with CMV promoter was introduced to liver using hemagglutinating virus of Japan (HVJ)-liposome via portal vein with clamp of left glisson. Control rats received **S injection in the same method. Two-thirds hepatectom … More y, according to the procedure described by Higgins and Anderson, was ***formed 3 days after HGF gene or PBS injection. On hours 6,12,24,72,168 after the two-thirds hepatectomy, rate were sacrificed and the blood sample and liver tissue were collected. DNA synthesis in hepatocytes was investigated with immunohistochemistry of proliferating cell nuclear antigen (PCNA). Apoptotic hepatocytes were determined by using the TUNEL assay. The expression of pro-apoptotic and anti-apoptotic protein, such as Bax and Bcl-xL, was analyzed by Western blotting.Results : In the control group, rat began to die 6 hours after hepatectomy, and 31.5% of rats died by 3 days. On the other hand, HGF gene transduction significantly improved mortality, and 92.7% of rats survived at 7days. DNA synthesis of hepatocytes in the HGF gene transferred rat liver determined with PCNA was higher than those in the control rat liver 3 days after hepatectomy while no significant difference in the remnant liver volume was observed between the groups. A number of apoptotic liver cells were observed with TUNEL method on early time course after the hepatectomy in the control group, whereas few apoptotic figures were detected in the HGF gene transferred liver. Though expression of anti-apoptotic proteins, Bcl-xL, has been shown to increase substantially in normal liver at early phase after hepatectomy, these proteins were remarkably inhibited in the cirrhotic rat liver in this study. HGF gene transfer into the cirrhotic livers significantly improved the expression of these proteins after hepatectomy. On the other hand, expression of pro-apoptotic protein Bax was not seen in normal rat liver by 3 days after hepatectomy, but this protein has been already expressed following hepatectomy in the control and HGF transducted rats. HGF gene transduction was not seen obvious effects against Bax protein in cirrhotic rats.Conclusion : After partial resection of cirrhotic liver, HGF gene therapy effectively prevented apoptosis of hepatocyte, suggesting that HGF worked as an anti-apoptotic agent rather than a regeneration-accelerating factor. This effect of HGF possibly inhibited the mortality in early time course after partial hepatectomy. Less
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
植木孝浩: "疾病克服への細胞増殖因子研究:肝硬変治療とHGF"Molecular Medicine. 38. 320-327 (2001)
Takahiro Ueki:“细胞生长因子克服疾病的研究:肝硬化和 HGF 的治疗”《分子医学》38. 320-327 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahiro Ueki: "Liver regeneration using Hepatocyte Growth factor"Geka. 63. 279-285 (2001)
Takahiro Ueki:“利用肝细胞生长因子进行肝脏再生”Geka。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahiro Ueki: "HGF Gene Therapy for Liver Cirrhosis"Jap.J Apheresis. 21. 122-126 (2002)
Takahiro Ueki:“肝硬化的 HGF 基因治疗”Jap.J Apheresis。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahiro Ueki: "Liver cirrhosis"Nippon Rinsho. 59. 152-156 (2001)
植木贵宏:《肝硬化》日本林正。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
6
    海外基金